Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey
AstraZeneca
Teva
Moodys
Fuji
Healthtrust
McKesson
Johnson and Johnson
Cipla

Generated: May 21, 2018

DrugPatentWatch Database Preview

Decitabine - Generic Drug Details

or, see our see our flat-rate plans

« Back to Dashboard

What are the generic drug sources for decitabine and what is the scope of decitabine freedom to operate?

Decitabine
is the generic ingredient in two branded drugs marketed by Otsuka Pharm Co Ltd, Accord Hlthcare, Chemi Spa, Cipla Ltd, Dr Reddys Labs Ltd, Pharmascience Inc, Sagent Pharms, Sandoz Inc, and Sun Pharma Global, and is included in nine NDAs. Additional information is available in the individual branded drug profile pages.

There are seventeen drug master file entries for decitabine. Ten suppliers are listed for this compound.
Pharmacology for decitabine
Synonyms for decitabine
1,3, 5-Triazin-2(1H)-one, 4-amino-1-(2-deoxy--D-erythro-pentofuranosyl)-
1,3,5-Triazin-2(1H)-one, 4-amino-1-(2-deoxy-beta-D-erythro-pentofuranosyl)-
105597-46-4
123795-43-7
2-deoxyazacytidine
2-Desoxy-5-azacytidine
2'-Deoxy-5-azacytidine
2353-33-5
353A335
4-amino-1-((2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-1,3,5-triazin-2(1H)-one
4-Amino-1-(2-deoxy-?-D-erythro-pentofuranosyl)-1,3,5-triazin-2(1H)-one
4-Amino-1-(2-deoxy-beta-D-erythro-pentofuranosyl)-1,3,5-triazin-2(1H)-one
4-amino-1-(2-deoxy-beta-d-erythro-pentofuranosyl)-s-triazin-2(1h)-on
4-Amino-1-(2-deoxy-beta-D-erythro-pentofuranosyl)-s-triazin-2(1H)-one
4-Amino-1-(2-deoxy-beta-D-ribofuranosyl)-1,3,5-triazin-2(1H)-one
4-amino-1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,2-dihydro-1,3,5-triazin-2-one
4-amino-1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,3,5-triazin-2-one
4-amino-1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-1,3,5-triazin-2-one
5-aza-2-deoxycytidine
5-Aza-2'-deoxycytidine
5-Aza-2'-deoxycytidine, >=97%
5-Aza-2&prime
5-Aza-2′-Deoxycytidine
5-aza-CdR
5-aza-dC
5-Aza-deoxycytidine
5-AZAdC
5-Azadeoxycytidine
5-Deoxy-2&prime
5-Deoxy-2′-azacytidine
5A2dc
776B62CQ27
AB0020011
AB00918337_08
AB00918337-07
ABP001084
AC-1135
AC1L9PS9
ACT00147
AKOS015895047
ANW-25144
API0002229
AS-17558
AzadC
BC677683
BCP0726000271
BCP9000593
BDBM96274
BIFK0051
BRN 0617982
C-13049
C8H12N4O4
CA-714
CAS-2353-33-5
CC-26303
cc-571
CCG-208143
CCRIS 8227
CHEBI:50131
CHEMBL1201129
cid_451668
CS-0372
CTK1A2018
D03665
D0X5XU
Dacogen
Dacogen (TN)
Dacogen, 5-aza-2'-deoxycytidine,NSC 127716, Dacogen, DAC, Decitabine
DB-029060
DB01262
decitabine (2 inverted exclamation marka-deoxy-5-azacytidine).cd
Decitabine (NSC127716, 5AZA-CdR)
Decitabine (USAN/INN)
Decitabine [USAN:INN:BAN]
decitabine mesilate
decitabine mesylate
deoxy-5-azacytidine
Dezocitidine
DSSTox_CID_10432
DSSTox_GSID_30432
DSSTox_RID_78849
DTXSID7030432
E-7373
EINECS 219-089-4
EOS114
EX-A961
FT-0082622
GTPL6805
HMS2235O03
HY-A0004
J-700084
J10097
JNJ 30979754
JNJ-30979754
KB-41703
MFCD00043011
MLS001332587
MLS001332588
MLS006010136
MolMap_000063
MolPort-003-925-958
NCGC_5ADOC
NCGC00166088-01
NCGC00166088-02
NCGC00166088-05
NSC 127716
NSC127716
NU004639
PubChem19115
RL02744
s-Triazin-2(1H)-one, 4-amino-1-(2-deoxy-beta-D-erythro-pentofuranosyl)-
s1200
SBB066121
SC-19951
SCHEMBL4006
SMR000857076
SR-01000838879
SR-01000838879-4
SYN3036
TL8001944
Tox21_112311
Tox21_112311_1
UNII-776B62CQ27
V0702
W-5049
XAUDJQYHKZQPEU-KVQBGUIXSA-N
ZINC16929327

US Patents and Regulatory Information for decitabine

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Chemi Spa DECITABINE decitabine INJECTABLE;INTRAVENOUS 206033-001 Sep 22, 2017 AP RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Otsuka Pharm Co Ltd DACOGEN decitabine INJECTABLE;INTRAVENOUS 021790-001 May 2, 2006 AP RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Cipla Ltd DECITABINE decitabine INJECTABLE;INTRAVENOUS 208601-001 Nov 16, 2017 AP RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Sagent Pharms DECITABINE decitabine INJECTABLE;INTRAVENOUS 207100-001 Mar 16, 2018 AP RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Dow
US Department of Justice
Chinese Patent Office
Julphar
Baxter
Johnson and Johnson
Mallinckrodt
Moodys
US Army

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.